Tizanidine
- Product NDC
- 63187-673
- 11-digit product format
- 631870673
- Labeler code
- 63187
- Product ID
- 63187-673_2b2e33aa-55ad-4969-85d1-9cbfb62cabbb
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tizanidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Proficient Rx LP
- Application
- ANDA076416
- Marketing category
- ANDA
- Marketing start
- 2003-12-11
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Tizanidine
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TIZANIDINE HYDROCHLORIDE | 4 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | B53E3NMY5C |
| Rxcui | 313413 |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 63187-673-14 | 63187067314 | 14 TABLET in 1 BOTTLE (63187-673-14) | 14 tablet | 2022-01-05 | 0000-00-00 | No | No | Current |
| 63187-673-30 | 63187067330 | 30 TABLET in 1 BOTTLE (63187-673-30) | 30 tablet | 2018-12-01 | 0000-00-00 | No | No | Current |
| 63187-673-60 | 63187067360 | 60 TABLET in 1 BOTTLE (63187-673-60) | 60 tablet | 2018-12-01 | 0000-00-00 | No | No | Current |
| 63187-673-90 | 63187067390 | 90 TABLET in 1 BOTTLE (63187-673-90) | 90 tablet | 2018-12-01 | 0000-00-00 | No | No | Current |